对胸腺瘤当代管理策略的直观评估-印度最大的经验。

IF 1.2 Q4 ONCOLOGY Reports of Practical Oncology and Radiotherapy Pub Date : 2023-08-28 eCollection Date: 2023-01-01 DOI:10.5603/RPOR.a2023.0050
Rahul Lal Chowdhary, Kundan Singh Chufal, Mohammed Ismail, Irfan Ahmad, M Jwala, Anjali K Pahuja, Lalit Kumar
{"title":"对胸腺瘤当代管理策略的直观评估-印度最大的经验。","authors":"Rahul Lal Chowdhary,&nbsp;Kundan Singh Chufal,&nbsp;Mohammed Ismail,&nbsp;Irfan Ahmad,&nbsp;M Jwala,&nbsp;Anjali K Pahuja,&nbsp;Lalit Kumar","doi":"10.5603/RPOR.a2023.0050","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim was perusal of the treatment strategies, clinical outcomes and factors impacting these outcomes in thymoma.</p><p><strong>Materials and methods: </strong>A total of 119 patients diagnosed and treated cases of thymoma, at our hospital, were taken for analysis. Thirty-one patients were excluded due to inadequate medical records. Descriptive statistics were used to report demographic and clinical characteristics. Time period between diagnosis and death was defined as overall survival (OS). Multivariate analysis (MVA), using cox regression modelling, was done by including clinicopathological factors in a bid to identify prognostic factors influencing OS. SPSS version 26 was used for statistical analysis.</p><p><strong>Results: </strong>The mean age of the patients was 52.17 years and 39 (44.3%), 19 (21.6%), 17 (1.3%) and 13 (4.8%) patients presented with Masaoka stage II, IV, III and I, respectively. Surgery was done in 64 (72.7%) of the patients as a part of the treatment strategy. Radiotherapy was administered to a total of 57 patients with a median dose of 50.4 Gy. Early Masaoka stage at presentation and use of surgery in the treatment plan were statistically significant prognostic factors for a better overall survival on multivariate analysis.</p><p><strong>Conclusion: </strong>Judicious use of radiotherapy and chemotherapy in locally advanced cases may render them resectable. In a bid to gain good survival rates, aggressive multimodality treatment should be offered to the patients.</p>","PeriodicalId":47283,"journal":{"name":"Reports of Practical Oncology and Radiotherapy","volume":"28 4","pages":"454-462"},"PeriodicalIF":1.2000,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/68/rpor-28-4-454.PMC10547419.pdf","citationCount":"0","resultStr":"{\"title\":\"Intuitive evaluation of contemporary management strategies in thymoma - the largest Indian experience.\",\"authors\":\"Rahul Lal Chowdhary,&nbsp;Kundan Singh Chufal,&nbsp;Mohammed Ismail,&nbsp;Irfan Ahmad,&nbsp;M Jwala,&nbsp;Anjali K Pahuja,&nbsp;Lalit Kumar\",\"doi\":\"10.5603/RPOR.a2023.0050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The aim was perusal of the treatment strategies, clinical outcomes and factors impacting these outcomes in thymoma.</p><p><strong>Materials and methods: </strong>A total of 119 patients diagnosed and treated cases of thymoma, at our hospital, were taken for analysis. Thirty-one patients were excluded due to inadequate medical records. Descriptive statistics were used to report demographic and clinical characteristics. Time period between diagnosis and death was defined as overall survival (OS). Multivariate analysis (MVA), using cox regression modelling, was done by including clinicopathological factors in a bid to identify prognostic factors influencing OS. SPSS version 26 was used for statistical analysis.</p><p><strong>Results: </strong>The mean age of the patients was 52.17 years and 39 (44.3%), 19 (21.6%), 17 (1.3%) and 13 (4.8%) patients presented with Masaoka stage II, IV, III and I, respectively. Surgery was done in 64 (72.7%) of the patients as a part of the treatment strategy. Radiotherapy was administered to a total of 57 patients with a median dose of 50.4 Gy. Early Masaoka stage at presentation and use of surgery in the treatment plan were statistically significant prognostic factors for a better overall survival on multivariate analysis.</p><p><strong>Conclusion: </strong>Judicious use of radiotherapy and chemotherapy in locally advanced cases may render them resectable. In a bid to gain good survival rates, aggressive multimodality treatment should be offered to the patients.</p>\",\"PeriodicalId\":47283,\"journal\":{\"name\":\"Reports of Practical Oncology and Radiotherapy\",\"volume\":\"28 4\",\"pages\":\"454-462\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/68/rpor-28-4-454.PMC10547419.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Practical Oncology and Radiotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/RPOR.a2023.0050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology and Radiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/RPOR.a2023.0050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:目的是仔细阅读胸腺瘤的治疗策略、临床结果和影响这些结果的因素。材料与方法:对我院收治的119例胸腺瘤患者进行分析。31名患者因医疗记录不足而被排除在外。描述性统计用于报告人口统计学和临床特征。诊断和死亡之间的时间段被定义为总生存期(OS)。采用cox回归模型进行多变量分析(MVA),包括临床病理因素,以确定影响OS的预后因素。采用SPSS 26进行统计分析。结果:患者的平均年龄为52.17岁,Masaoka II、IV、III和I期患者分别为39例(44.3%)、19例(21.6%)、17例(1.3%)和13例(4.8%)。作为治疗策略的一部分,64名(72.7%)患者接受了手术治疗。共有57名患者接受了放射治疗,中位剂量为50.4 Gy。多变量分析显示,Masaoka早期阶段和治疗计划中手术的使用是提高总生存率的具有统计学意义的预后因素。结论:在局部晚期病例中,正确使用放疗和化疗可以使其切除。为了获得良好的生存率,应该为患者提供积极的多模式治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Intuitive evaluation of contemporary management strategies in thymoma - the largest Indian experience.

Background: The aim was perusal of the treatment strategies, clinical outcomes and factors impacting these outcomes in thymoma.

Materials and methods: A total of 119 patients diagnosed and treated cases of thymoma, at our hospital, were taken for analysis. Thirty-one patients were excluded due to inadequate medical records. Descriptive statistics were used to report demographic and clinical characteristics. Time period between diagnosis and death was defined as overall survival (OS). Multivariate analysis (MVA), using cox regression modelling, was done by including clinicopathological factors in a bid to identify prognostic factors influencing OS. SPSS version 26 was used for statistical analysis.

Results: The mean age of the patients was 52.17 years and 39 (44.3%), 19 (21.6%), 17 (1.3%) and 13 (4.8%) patients presented with Masaoka stage II, IV, III and I, respectively. Surgery was done in 64 (72.7%) of the patients as a part of the treatment strategy. Radiotherapy was administered to a total of 57 patients with a median dose of 50.4 Gy. Early Masaoka stage at presentation and use of surgery in the treatment plan were statistically significant prognostic factors for a better overall survival on multivariate analysis.

Conclusion: Judicious use of radiotherapy and chemotherapy in locally advanced cases may render them resectable. In a bid to gain good survival rates, aggressive multimodality treatment should be offered to the patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
8.30%
发文量
115
审稿时长
16 weeks
期刊介绍: Reports of Practical Oncology and Radiotherapy is an interdisciplinary bimonthly journal, publishing original contributions in clinical oncology and radiotherapy, as well as in radiotherapy physics, techniques and radiotherapy equipment. Reports of Practical Oncology and Radiotherapy is a journal of the Polish Society of Radiation Oncology, the Czech Society of Radiation Oncology, the Hungarian Society for Radiation Oncology, the Slovenian Society for Radiotherapy and Oncology, the Polish Study Group of Head and Neck Cancer, the Guild of Bulgarian Radiotherapists and the Greater Poland Cancer Centre, affiliated with the Spanish Society of Radiotherapy and Oncology, the Italian Association of Radiotherapy and the Portuguese Society of Radiotherapy - Oncology.
期刊最新文献
Prehabilitation approaches for gastrointestinal cancer surgery: a narrative review. Reirradiation of gliomas with hypofractionated stereotactic radiotherapy: efficacy and tolerance analysis at a single center. Tracing prostate cancer - the evolution of PET-CT applications. Treatment of oropharyngeal cancer during the COVID-19 lockdown - outcomes for patients treated during the pandemic. Can the reprogrammed cancer cells serve as an alternative source of (induced) cancer stem cells?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1